AstraZeneca secures US FDA approval for pre-filled auto-injector FASENRA Pen
UK-based biopharmaceutical company AstraZeneca has secured the US Food and Drug Administration (FDA) approval for self-administration of FASENRA (benralizumab) through a pre-filled, single-use auto-injector, FASENRA Pen. AstraZeneca said